Sientra Inc.
- UEI
- MW6KWX2KYPL9
- CAGE
- 3DHK0
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- sientra.com
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$17,359 |
| FY2024 | -$47,693 |
| FY2023 | $147,360 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Sientra Inc. is a self-certified small disadvantaged business registered in SAM.gov since 2003, specializing in manufacturing medical aesthetic products, particularly silicone gel breast implants, breast tissue expanders, and related medical devices. Based in Irvine, California, the company provides high-quality implantable medical products primarily to federal healthcare agencies, with a strong focus on supporting breast cancer treatment, reconstruction procedures, and cosmetic surgeries for veterans and active-duty military personnel.
Through its federal contract awards, Sientra Inc. has consistently supplied breast implants, tissue expanders, and related medical devices to multiple federal agencies, including the Department of Veterans Affairs (VA), Veterans Integrated Service Networks (VISN), Defense Health Agency (DHA), and Army Medical Command. The company has been awarded numerous purchase orders and blanket purchase agreement (BPA) call contracts, with individual award values ranging from $150 to over $1.1 million. These contracts have been predominantly firm fixed-price purchase orders and BPA calls, covering products such as HSC+ gel breast implants, silicone gel sizers, and pre-surgical breast implants. No set-aside designations were used in these awards, indicating Sientra's ability to compete effectively in the open federal market for medical supplies.
Sientra Inc. currently holds two significant federal contract indefinite delivery/indefinite quantity (IDIQ) blanket purchase agreements. The first BPA, awarded by the Army Medical Command in December 2022, has a $2,500,000 ceiling and covers Opus and Teardrop breast implants and breast tissue expanders, with an ultimate completion date of November 30, 2027. The second BPA, awarded in September 2021, has a $100,000 ceiling specifically for breast tissue expanders and concludes on September 19, 2023. These BPAs enable military treatment facilities and VA medical centers to efficiently procure Sientra's medical devices, supporting critical healthcare needs across the military and veterans' healthcare systems.
SBA capabilities narrative
At Sientra, we are committed to providing plastic surgeons with intuitive, elegant solutions-as reflected in our innovative round and shaped product lines.
Quick answers
Is Sientra Inc. registered in SAM.gov?
Sientra Inc.'s SAM.gov registration expired on March 13, 2025.
How much has Sientra Inc. received in federal contracts?
Federal contracts obligated $82,308 to Sientra Inc. in fiscal years 2023 through 2027.
What is Sientra Inc.'s most recent federal award?
Sientra Inc.'s most recent federal contract award is Surgical breast implants (36C24125P0418), from Veterans Integrated Service Network 1 (VHA), on March 25, 2025.
On GovTribe
See Sientra Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors